The dysregulation of BACE1AS is associated with upregulated BACE1 activity in several human disorders, including Alzheimer’s disease, Parkinson’s disease, heart failure, and MCI, indicating a potential influential role of BACE1AS in the progression of these diseases [23]. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.